FDA Accepts Ultragenyx’s New BLA Submission for MPS IIIA Gene Therapy UX111

News release. Ultragenyx Pharmaceutical Inc. April 2, 2026. Accessed April 9, 2026. https://ir.ultragenyx.com/news-releases/news-release-details …